A randomized, triple masked, placebo-controlled clinical trial for controlling childhood obesity

World Journal of Pediatrics

Volumn 6, Issue 4, 2010, Pages 317-322

  Rezvanian, Hasan ^a   Hashemipour, Mahin ^a   Kelishadi, Roya ^a   Tavakoli, Naser ^b   Poursafa, Parinaz ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Science and Research University   (Iran)

Author keywords

abdominal obesity; childhood obesity; fluoxetine; generalized obesity; metformin; treatment

Indexed keywords

FLUOXETINE; METFORMIN; PLACEBO;

ABDOMINAL OBESITY; ABDOMINAL PAIN; ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG INDUCED HEADACHE; EXERCISE; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; LOOSE FECES; MAJOR CLINICAL STUDY; OBESITY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; TREATMENT DURATION; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; XEROSTOMIA;

ADOLESCENT; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FLUOXETINE; HUMANS; MALE; METFORMIN; OBESITY;

EID: 78649638455     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-010-0232-x     Document Type: Article

References (35)

1. C.B. Ebbeling D.B. Pawlak D.S. Ludwig 2002 Childhood obesity: public-health crisis, common sense cure Lancet 360 473 482 10.1016/S0140- 6736(02)09678-2 12241736 (Pubitemid 34880150)
2. R. Kelishadi 2007 Childhood overweight, obesity, and the metabolic syndrome in developing countries Epidemiol Rev 29 62 76 10.1093/epirev/mxm003 17478440 (Pubitemid 47229639)
3. R. Kelishadi G. Ardalan R. Gheiratmand M.M. Gouya E.M. Razaghi A. Delavari, et al. 2007 Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study Bull World Health Organ 85 19 26 17242754
4. R.J. Deckelbaum C.L. Williams 2001 Childhood obesity: the health issue Obes Res 9 Suppl4 239S 243S 10.1038/oby.2001.125 11707548
5. M. Hashemipour R. Kelishadi S. Asgary M. Talaei M. Salek N. Mohammadifard, et al. 2006 Efficacy of herbal mixtures in childhood obesity control J Ped Neonat 3 1 5
6. G.A. Medeiros-Neto 1993 Should drug be used for treating obese children? Int J obse Relat Metab disord 17 363 365 1:STN:280:DyaK3szit1Wmtw%3D%3D
7. D. Molnár K. Török E. Erhardt S. Jeges 2000 Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents Int J Obes Relat Metab Disord 24 1573 1578 10.1038/sj.ijo.0801433 11126208
8. M. Freemark D. Bursey 2001 The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes Pediatrics 107 E55 1:STN:280: DC%2BD3M3ptVCisA%3D%3D 10.1542/peds.107.4.e55 11335776
9. K. Love-Osborne J. Sheeder P. Zeitler 2008 Addition of metformin to a lifestyle modification program in adolescents with insulin resistance J Pediatr 152 817 822 1:CAS:528:DC%2BD1cXlvFymtrs%3D 10.1016/j.jpeds.2008.01.018 18492523
10. E. Webb R. Viner 2006 Should metformin be prescribed to overweight adolescents in whom dietary/behavioural modifications have not helped? Arch Dis Child 91 793 794 1:STN:280:DC%2BD28vpvVCrtw%3D%3D 10.1136/adc.2006.098962 16923867 (Pubitemid 44351188)
11. N. Uli S. Sundararajan L. Cuttler 2008 Treatment of childhood obesity Curr Opin Endocrinol Diabetes Obes 15 37 47 18185061
12. C.J. Glueck R.N. Fontaine P. Wang M.T. Subbiah K. Weber E. Illig, et al. 2001 Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30 Metabolism 50 856 861 1:CAS:528: DC%2BD3MXlt1Krsr4%3D 10.1053/meta.2001.24192 11436194 (Pubitemid 32700469)
13. M.A. Charles E. Eschwege P. Grandmottet F. Isnard J.M. Cohen J.L. Bensoussan, et al. 2000 Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial Diabetes Metab Res Rev 16 2 7 1:CAS:528:DC%2BD3cXivVSrsL4%3D 10.1002/(SICI)1520-7560(200001/02)16:1<2::AID-DMRR75>3.0.CO;2-G 10707032 (Pubitemid 30160610)
14. J. Lord T. Wilkin 2004 Metformin in polycystic ovary syndrome Curr Opin Obstet Gynecol 16 481 486 10.1097/00001703-200412000-00008 15534444 (Pubitemid 41015899)
15. E. Mannucci A. Ognibene F. Cremasco G. Bardini A. Mencucci E. Pierazzuoli, et al. 2001 Effect of metformin on glucagonlike peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects Diabetes Care 24 489 494 1:CAS:528:DC%2BD3MXit1erur0%3D 10.2337/diacare.24.3.489 11289473
16. S. Srinivasan G.R. Ambler L.A. Baur S.P. Garnett M. Tepsa F. Yap, et al. 2006 Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin J Clin Endocrinol Metab 91 2074 2080 1:CAS:528: DC%2BD28XlvVCgsrc%3D 10.1210/jc.2006-0241 16595599 (Pubitemid 43854985)
17. Fluoxetine and other drugs for treatment of obesity. Med Lett Drugs Ther 1994;36:107-108.
18. J.C. Halford J.A. Harrold 2008 Neuropharmacology of human appetite expression Dev Disabil Res Rev 14 158 164 10.1002/ddrr.20 18646016
19. J.C. Halford J.A. Harrold E.J. Boyland C.L. Lawton J.E. Blundell 2007 Serotonergic drugs: effects on appetite expression and use for the treatment of obesity Drugs 67 27 55 1:CAS:528:DC%2BD2sXitFGltLw%3D 10.2165/00003495- 200767010-00004 17209663 (Pubitemid 46105086)
20. J.C. Halford J.A. Harrold C.L. Lawton J.E. Blundell 2005 Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity Curr Drug Targets 6 201 213 1:CAS:528:DC%2BD2MXisVSqu74%3D 15777190
21. M.S. Dastjerdi F. Kazemi A. Najafian M. Mohammady A. Aminorroaya M. Amini 2007 An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction Int J Obes (Lond) 31 713 717
22. R.J. Kuczmarski C.L. Ogden L.M. Grummer-Strawn K.M. Flegal S.S. Guo R. Wei, et al. 2000 CDC growth charts: United States Adv Data 314 1 27 11183293
23. C.K. Roberts A.K. Chen R.J. Barnard 2007 Effect of a short-term diet and exercise intervention in youth on atherosclerotic risk factors Atherosclerosis 191 98 106 1:CAS:528:DC%2BD2sXhvVGntrk%3D 10.1016/j.atherosclerosis.2006.09.011 17054960 (Pubitemid 46237630)
24. R. Kelishadi M. Hashemi N. Mohammadifard S. Asgary N. Khavarian 2008 Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children Clin Chem 54 147 153 1:CAS:528:DC%2BD1cXmtFektw%3D%3D 10.1373/clinchem.2007.089953 17998270 (Pubitemid 351182608)
25. R. Kelishadi G. Ardalan R. Gheiratmand R. Majdzadeh M. Hosseini M.M. Gouya, et al. 2008 Thinness, overweight and obesity in a national sample of Iranian children and adolescents: CASPIAN Study Child Care Health Dev 34 44 54 1:STN:280:DC%2BD1c%2FgsF2ktw%3D%3D 18171443
26. S. Cook P. Auinger C. Li E.S. Ford 2008 Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002 J Pediatr 152 165 170 10.1016/j.jpeds.2007.06.004 18206683
27. R.A. Feinstein 2004 Physical activity should be promoted at every well-child visit AAP News 24 120
28. Centers for Disease Control and Prevention. http://www.cdc.gov/ physicalactivity/everyone/guidelines/children.html (accessed February 24, 2009).
29. Lucas B. Nutrition in Childhood. In: Mahan LK, Escott-Stumps, eds. Kraue's Food, Nutrition & Diet Therapy, 10th ed. Saunders: Philadelphia, 2000: 242-245.
30. M.E. Atabek O. Pirgon 2008 Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial J Pediatr Endocrinol Metab 21 339 348 1:CAS:528: DC%2BD1cXnvVCqsbw%3D 18556965
31. R. Pasquali A. Gambineri D. Biscotti V. Vicennati L. Gagliardi D. Colitta, et al. 2000 Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome J Clin Endocrinol Metab 85 2767 2774 1:CAS:528:DC%2BD3cXnslahsrY%3D 10.1210/jc.85.8.2767 10946879 (Pubitemid 32269149)
32. K. Hoeger K. Davidson L. Kochman T. Cherry L. Kopin D.S. Guzick 2008 The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials J Clin Endocrinol Metab 93 4299 4306 1:CAS:528:DC%2BD1cXhtlyqs7nF 10.1210/jc.2008-0461 18728175 (Pubitemid 352789525)
33. P. Leombruni A. Pierò L. Lavagnino A. Brustolin S. Campisi S. Fassino 2008 A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder Prog Neuropsychopharmacol Biol Psychiatry 32 1599 1605 1:CAS:528:DC%2BD1cXptVeqsbk%3D 10.1016/j.pnpbp.2008.06.005 18598735
34. C. Guimarães L.R. Pereira N. Iucif Júnior E.J. Cesarino C.A. de Almeida D. de Carvalho, et al. 2006 Tolerability and effectiveness of fluoxetine, metformin and sibutramine in reducing anthropometric and metabolic parameters in obese patients Arq Bras Endocrinol Metabol 50 1020 1025 17221107
35. Marcus C. Pharmacological Treatment of Childhood Obesity. In: Kiess W, Marcus C, Wabitsch M, eds. Obesity in Childhood and Adolescence. Pediatr Adolesc Med, Basel: Karger, 2004: 211-228.